Lisata Therapeutics (LSTA) Earnings Date & Reports
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LSTA is expected to report earnings to rise 16.36% to -63 cents per share on August 18
Q2'25
Est.
$-0.64
Q1'25
Beat
by $0.19
Q4'24
Beat
by $0.30
Q3'24
Beat
by $0.16
Q2'24
Beat
by $0.14
The last earnings report on May 09 showed earnings per share of -55 cents, beating the estimate of -74 cents. With 11.09K shares outstanding, the current market capitalization sits at 19.65M.